A citation-based method for searching scientific literature

Giuseppe Pantaleo, Bruno Correia, Craig Fenwick, Victor S Joo, Laurent Perez. Nat Rev Drug Discov 2022
Times Cited: 5







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SARS-CoV-2 variants, spike mutations and immune escape.
William T Harvey, Alessandro M Carabelli, Ben Jackson, Ravindra K Gupta, Emma C Thomson, Ewan M Harrison, Catherine Ludden, Richard Reeve, Andrew Rambaut, Sharon J Peacock,[...]. Nat Rev Microbiol 2021
40

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
Delphine Planas, Nell Saunders, Piet Maes, Florence Guivel-Benhassine, Cyril Planchais, Julian Buchrieser, William-Henry Bolland, Françoise Porrot, Isabelle Staropoli, Frederic Lemoine,[...]. Nature 2022
538
40

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
Emi Takashita, Noriko Kinoshita, Seiya Yamayoshi, Yuko Sakai-Tagawa, Seiichiro Fujisaki, Mutsumi Ito, Kiyoko Iwatsuki-Horimoto, Shiho Chiba, Peter Halfmann, Hiroyuki Nagai,[...]. N Engl J Med 2022
128
40

Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
Myron J Levin, Andrew Ustianowski, Stéphane De Wit, Odile Launay, Miles Avila, Alison Templeton, Yuan Yuan, Seth Seegobin, Adam Ellery, Dennis J Levinson,[...]. N Engl J Med 2022
107
40

Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.
Dominique Bertrand, Charlotte Laurent, Veronique Lemée, Ludivine Lebourg, Mélanie Hanoy, Frank Le Roy, Dorian Nezam, Diana Pruteanu, Steven Grange, Tristan de Nattes,[...]. Kidney Int 2022
7
40


SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
40

Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design.
Daniel A Cannon, Lu Shan, Qun Du, Lena Shirinian, Keith W Rickert, Kim L Rosenthal, Martin Korade, Lilian E van Vlerken-Ysla, Andrew Buchanan, Tristan J Vaughan,[...]. PLoS Comput Biol 2019
22
20

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
Christopher O Barnes, Claudia A Jette, Morgan E Abernathy, Kim-Marie A Dam, Shannon R Esswein, Harry B Gristick, Andrey G Malyutin, Naima G Sharaf, Kathryn E Huey-Tubman, Yu E Lee,[...]. Nature 2020
725
20

Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants.
Bo-Seong Jeong, Jeong Seok Cha, Insu Hwang, Uijin Kim, Jared Adolf-Bryfogle, Brian Coventry, Hyun-Soo Cho, Kyun-Do Kim, Byung-Ha Oh. MAbs 2022
2
50

Site-specific glycan analysis of the SARS-CoV-2 spike.
Yasunori Watanabe, Joel D Allen, Daniel Wrapp, Jason S McLellan, Max Crispin. Science 2020
812
20


A de novo protein binding pair by computational design and directed evolution.
John Karanicolas, Jacob E Corn, Irwin Chen, Lukasz A Joachimiak, Orly Dym, Sun H Peck, Shira Albeck, Tamar Unger, Wenxin Hu, Gaohua Liu,[...]. Mol Cell 2011
129
20

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
Bo Meng, Adam Abdullahi, Isabella A T M Ferreira, Niluka Goonawardane, Akatsuki Saito, Izumi Kimura, Daichi Yamasoba, Pehuén Pereyra Gerber, Saman Fatihi, Surabhi Rathore,[...]. Nature 2022
204
20

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio Cc Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis,[...]. Elife 2020
819
20


LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants.
Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Robin van der Lee, Jörg Hendle, Anna Pustilnik,[...]. Cell Rep 2022
93
20

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants.
Hung Fu Tseng, Bradley K Ackerson, Yi Luo, Lina S Sy, Carla A Talarico, Yun Tian, Katia J Bruxvoort, Julia E Tubert, Ana Florea, Jennifer H Ku,[...]. Nat Med 2022
146
20

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies.
Yunlong Cao, Jing Wang, Fanchong Jian, Tianhe Xiao, Weiliang Song, Ayijiang Yisimayi, Weijin Huang, Qianqian Li, Peng Wang, Ran An,[...]. Nature 2022
515
20

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
Delphine Planas, David Veyer, Artem Baidaliuk, Isabelle Staropoli, Florence Guivel-Benhassine, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Nicolas Robillard, Julien Puech,[...]. Nature 2021
20


AbDesign: An algorithm for combinatorial backbone design guided by natural conformations and sequences.
Gideon D Lapidoth, Dror Baran, Gabriele M Pszolla, Christoffer Norn, Assaf Alon, Michael D Tyka, Sarel J Fleishman. Proteins 2015
57
20


A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.
Federico Bertoglio, Viola Fühner, Maximilian Ruschig, Philip Alexander Heine, Leila Abassi, Thomas Klünemann, Ulfert Rand, Doris Meier, Nora Langreder, Stephan Steinke,[...]. Cell Rep 2021
37
20

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.
Matthew McCallum, Nadine Czudnochowski, Laura E Rosen, Samantha K Zepeda, John E Bowen, Alexandra C Walls, Kevin Hauser, Anshu Joshi, Cameron Stewart, Josh R Dillen,[...]. Science 2022
170
20

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.
Tyler N Starr, Allison J Greaney, Sarah K Hilton, Daniel Ellis, Katharine H D Crawford, Adam S Dingens, Mary Jane Navarro, John E Bowen, M Alejandra Tortorici, Alexandra C Walls,[...]. Cell 2020
959
20

Serological pattern "anti-HBc alone": report on a workshop.
P Grob, W Jilg, H Bornhak, G Gerken, W Gerlich, S Günther, G Hess, H Hüdig, A Kitchen, H Margolis,[...]. J Med Virol 2000
191
20

Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
Tiffany Wu, Ryan M Kwok, Tram T Tran. Am J Gastroenterol 2017
23
20

Advances in human monoclonal antibody therapy for HBV infection.
Maxime Beretta, Hugo Mouquet. Curr Opin Virol 2022
3
33


Antibody Therapy for the Control of Viral Diseases: An Update.
Miriam Dibo, Eduardo C Battocchio, Lucas M Dos Santos Souza, Matheus D Veloso da Silva, Bruna K Banin-Hirata, Milena M M Sapla, Poliana Marinello, Sérgio P D Rocha, Lígia C Faccin-Galhardi. Curr Pharm Biotechnol 2019
15
20

Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection.
C M Lee, S N Lu, C S Changchien, C T Yeh, T T Hsu, J H Tang, J H Wang, D Y Lin, C L Chen, W J Chen. Cancer 1999
141
20


Protection against hepatitis B virus infection by immunization with hepatitis B core antigen.
S Iwarson, E Tabor, H C Thomas, P Snoy, R J Gerety. Gastroenterology 1985
105
20

Transbody against hepatitis B virus core protein inhibits hepatitis B virus replication in vitro.
Yawen Wang, Yiping Li, Na Li, Qianqian Zhu, Lingyun Hui, Xi Liu, Qunying Han, Yi Lv, Quanying Wang, Guangxiao Yang,[...]. Int Immunopharmacol 2015
6
20

Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.
Feng-Qin Hou, Liu-Wei Song, Quan Yuan, Lin-Lin Fang, Sheng-Xiang Ge, Jun Zhang, Ji-Fang Sheng, Dong-Ying Xie, Jia Shang, Shu-Huan Wu,[...]. Theranostics 2015
46
20

Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus.
Yiping Li, Zhengwen Liu, Lingyun Hui, Xi Liu, Ai Feng, Wei Wang, Lin Zhang, Na Li, Guoqing Zhou, Quanli Wang,[...]. Br J Pharmacol 2017
4
25

Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice.
Lei Ye, Haisheng Yu, Chengwen Li, Matthew L Hirsch, Liguo Zhang, R Jude Samulski, Wuping Li, Zhong Liu. PLoS One 2015
25
20

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.
Tian-Ying Zhang, Quan Yuan, Jing-Hua Zhao, Ya-Li Zhang, Lun-Zhi Yuan, Ying Lan, Yu-Chieh Lo, Cheng-Pu Sun, Chang-Ru Wu, Jun-Fang Zhang,[...]. Gut 2016
77
20

Gender disparity in chronic hepatitis B: Mechanisms of sex hormones.
Sheng-Han Wang, Pei-Jer Chen, Shiou-Hwei Yeh. J Gastroenterol Hepatol 2015
63
20

A mouse model for HBV immunotolerance and immunotherapy.
Dan Yang, Longchao Liu, Danming Zhu, Hua Peng, Lishan Su, Yang-Xin Fu, Liguo Zhang. Cell Mol Immunol 2014
77
20

Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavir.
J-H Xu, L-W Song, N Li, S Wang, Z Zeng, C-W Si, J Li, Q Mao, D-Z Zhang, H Tang,[...]. J Viral Hepat 2017
20
20



Direct role of antibody-secreting B cells in the severity of chronic hepatitis B.
Ayaid Khadem Zgair, Jenan A Ghafil, Razaq H E Al-Sayidi. J Med Virol 2015
17
20

ADCC-Mediated CD56DIM NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection.
Wen-Han Yu, Cormac Cosgrove, Christoph T Berger, Patrick C Cheney, Marina Krykbaeva, Arthur Y Kim, Lia Lewis-Ximenez, Georg M Lauer, Galit Alter. Pathog Immun 2018
14
20

Humoral immunity, the underestimated player in hepatitis B.
Shuye Zhang, Juanjuan Zhao, Zheng Zhang. Cell Mol Immunol 2018
10
20

Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
Ying Gao, Tian-Ying Zhang, Quan Yuan, Ning-Shao Xia. Hum Vaccin Immunother 2017
21
20




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.